PHARMAEXEC: TALK OF THE TOWN

REMS programs. Megamergers. Generic encroachment. New sampling guidelines. The “unknowns” in the pharma industry have never been more prevalent or complex. But despite volumes of lagging prescription data and recall-based market research, pharma is still struggling to understand and anticipate how each new industry issue will impact current and future success. The key to understanding…

MEDAD NEWS: AD-VENTURES IN MARKETING

This past September, Med Ad News be- gan its now-annual search for the future of pharmaceutical marketing. We sought out young companies to profile that are provid- ing the most innovative and interesting prod- ucts, services, or marketing opportunities to pharmaceutical companies and the healthcare community. After reviewing dozens of nomi- nations, many of which…

SALES FORCE REPORT: THE ONLINE REP

Just a few short years ago most doctors were technophobic.You would have been hard-pressed to get an physican to consider electronic prescribing or logging-on to web-based medical conference. What a difference a few years can make. According to Manhattan Research, in 2009 ,87% of US physicians are considered “ePharma” physicians. In others words , they…